vs
Side-by-side financial comparison of Lifeway Foods, Inc. (LWAY) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.
Lifeway Foods, Inc. is the larger business by last-quarter revenue ($55.4M vs $49.0M, roughly 1.1× Quipt Home Medical Corp.). Lifeway Foods, Inc. runs the higher net margin — 4.6% vs -2.1%, a 6.7% gap on every dollar of revenue. On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs 18.0%). Quipt Home Medical Corp. produced more free cash flow last quarter ($6.9M vs $-17.4M).
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
LWAY vs QIPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $49.0M |
| Net Profit | $2.5M | $-1.1M |
| Gross Margin | 27.8% | 53.5% |
| Operating Margin | 6.8% | 2.1% |
| Net Margin | 4.6% | -2.1% |
| Revenue YoY | 18.0% | 32.3% |
| Net Profit YoY | 1688.1% | 2.9% |
| EPS (diluted) | $0.15 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.4M | $49.0M | ||
| Q3 25 | $57.1M | $39.8M | ||
| Q2 25 | $53.9M | $35.1M | ||
| Q1 25 | $46.1M | $33.3M | ||
| Q4 24 | $46.9M | $37.1M | ||
| Q3 24 | $46.1M | — | ||
| Q2 24 | $49.2M | — | ||
| Q1 24 | $44.6M | — |
| Q4 25 | $2.5M | $-1.1M | ||
| Q3 25 | $3.5M | $-3.5M | ||
| Q2 25 | $4.2M | $-3.0M | ||
| Q1 25 | $3.5M | $-3.0M | ||
| Q4 24 | $-160.0K | $-1.1M | ||
| Q3 24 | $3.0M | — | ||
| Q2 24 | $3.8M | — | ||
| Q1 24 | $2.4M | — |
| Q4 25 | 27.8% | 53.5% | ||
| Q3 25 | 28.7% | 48.7% | ||
| Q2 25 | 28.6% | 57.6% | ||
| Q1 25 | 23.9% | 54.6% | ||
| Q4 24 | 25.3% | 52.1% | ||
| Q3 24 | 25.7% | — | ||
| Q2 24 | 27.0% | — | ||
| Q1 24 | 25.8% | — |
| Q4 25 | 6.8% | 2.1% | ||
| Q3 25 | 8.8% | -3.6% | ||
| Q2 25 | 10.8% | -5.2% | ||
| Q1 25 | 3.4% | -3.0% | ||
| Q4 24 | 1.5% | 1.2% | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 8.0% | — |
| Q4 25 | 4.6% | -2.1% | ||
| Q3 25 | 6.2% | -8.9% | ||
| Q2 25 | 7.9% | -8.6% | ||
| Q1 25 | 7.7% | -9.1% | ||
| Q4 24 | -0.3% | -2.9% | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 7.7% | — | ||
| Q1 24 | 5.4% | — |
| Q4 25 | $0.15 | $-0.02 | ||
| Q3 25 | $0.23 | $-0.07 | ||
| Q2 25 | $0.28 | $-0.07 | ||
| Q1 25 | $0.23 | $-0.07 | ||
| Q4 24 | $0.00 | $-0.03 | ||
| Q3 24 | $0.19 | — | ||
| Q2 24 | $0.25 | — | ||
| Q1 24 | $0.16 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $10.5M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $85.8M | $113.0M |
| Total Assets | $105.6M | $280.7M |
| Debt / EquityLower = less leverage | — | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $10.5M | ||
| Q3 25 | $23.0M | $12.9M | ||
| Q2 25 | $21.2M | $11.3M | ||
| Q1 25 | $19.4M | $17.1M | ||
| Q4 24 | $16.7M | $15.5M | ||
| Q3 24 | $20.6M | — | ||
| Q2 24 | $14.6M | — | ||
| Q1 24 | $12.0M | — |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.5M | — |
| Q4 25 | $85.8M | $113.0M | ||
| Q3 25 | $82.8M | $112.1M | ||
| Q2 25 | $78.7M | $102.5M | ||
| Q1 25 | $74.2M | $103.6M | ||
| Q4 24 | $71.9M | $106.3M | ||
| Q3 24 | $71.5M | — | ||
| Q2 24 | $68.0M | — | ||
| Q1 24 | $63.5M | — |
| Q4 25 | $105.6M | $280.7M | ||
| Q3 25 | $109.5M | $283.3M | ||
| Q2 25 | $98.3M | $236.1M | ||
| Q1 25 | $93.7M | $244.6M | ||
| Q4 24 | $90.5M | $242.8M | ||
| Q3 24 | $91.3M | — | ||
| Q2 24 | $84.9M | — | ||
| Q1 24 | $82.8M | — |
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $267.0K | $8.9M |
| Free Cash FlowOCF − Capex | $-17.4M | $6.9M |
| FCF MarginFCF / Revenue | -31.5% | 14.0% |
| Capex IntensityCapex / Revenue | 31.9% | 4.2% |
| Cash ConversionOCF / Net Profit | 0.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.4M | $26.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $267.0K | $8.9M | ||
| Q3 25 | $6.9M | $9.8M | ||
| Q2 25 | $3.9M | $9.7M | ||
| Q1 25 | $-150.0K | $8.9M | ||
| Q4 24 | $-2.6M | $9.3M | ||
| Q3 24 | $7.5M | — | ||
| Q2 24 | $6.5M | — | ||
| Q1 24 | $1.5M | — |
| Q4 25 | $-17.4M | $6.9M | ||
| Q3 25 | $1.8M | $8.0M | ||
| Q2 25 | $1.6M | $4.4M | ||
| Q1 25 | $-2.4M | $7.3M | ||
| Q4 24 | $-3.8M | $5.6M | ||
| Q3 24 | $5.9M | — | ||
| Q2 24 | $5.1M | — | ||
| Q1 24 | $-923.0K | — |
| Q4 25 | -31.5% | 14.0% | ||
| Q3 25 | 3.1% | 20.0% | ||
| Q2 25 | 3.0% | 12.6% | ||
| Q1 25 | -5.1% | 22.0% | ||
| Q4 24 | -8.2% | 15.2% | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | 10.4% | — | ||
| Q1 24 | -2.1% | — |
| Q4 25 | 31.9% | 4.2% | ||
| Q3 25 | 9.0% | 4.6% | ||
| Q2 25 | 4.3% | 14.9% | ||
| Q1 25 | 4.8% | 4.8% | ||
| Q4 24 | 2.7% | 9.9% | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | 2.9% | — | ||
| Q1 24 | 5.5% | — |
| Q4 25 | 0.11× | — | ||
| Q3 25 | 1.96× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | -0.04× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.50× | — | ||
| Q2 24 | 1.73× | — | ||
| Q1 24 | 0.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
QIPT
Segment breakdown not available.
